Wellington-based company Volpara Health Technologies, which specialises in breast cancer detection tech, has seen a 57% increase in revenue for the year ended March 31 to just under $20 million on the back of several significant acquisitions, despite initial fears Covid would deter preventative
Want to read more? It's easy.
Choose your best value subscription option
Student
Exclusive offer for uni students studying at a New Zealand university (valued at $499).
